Discovery Labs (DSCO) Comments on Surfaxin End of Review FDA Meeting

July 1, 2009 5:14 PM EDT Send to a Friend
Discovery Laboratories, Inc. (Nasdaq: DSCO) announces today, after receipt of written minutes from the United States FDA, the results of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login